HealthCare Global Enterprises Limited (BOM:539787)
India · Delayed Price · Currency is INR 567.55
-29.45 (-4.93%)
At close: Feb 6, 2026
BOM:539787 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 24,716 | 22,181 | 19,079 | 16,914 | 13,948 | 10,092 |
Other Revenue | 66.74 | 47.14 | 42.48 | 30.33 | 30.05 | 42.5 |
| 24,782 | 22,229 | 19,121 | 16,944 | 13,978 | 10,134 | |
Revenue Growth (YoY) | 16.22% | 16.25% | 12.85% | 21.22% | 37.92% | -7.50% |
Cost of Revenue | 12,026 | 10,319 | 8,646 | 7,747 | 6,457 | 4,860 |
Gross Profit | 12,756 | 11,910 | 10,475 | 9,198 | 7,521 | 5,274 |
Selling, General & Admin | 732.02 | 732.02 | 619.64 | 448.05 | 273.86 | 189.58 |
Other Operating Expenses | 7,443 | 7,188 | 6,553 | 5,442 | 4,869 | 3,826 |
Operating Expenses | 10,666 | 10,130 | 8,921 | 7,842 | 6,725 | 5,608 |
Operating Income | 2,090 | 1,780 | 1,555 | 1,355 | 795.46 | -333.74 |
Interest Expense | -1,678 | -1,443 | -979.33 | -904.6 | -831.05 | -1,137 |
Interest & Investment Income | 158.82 | 158.82 | 126.97 | 118.1 | 115.61 | 156.11 |
Earnings From Equity Investments | 8.51 | 7.71 | 3.88 | -0.18 | -14.25 | -3.65 |
Currency Exchange Gain (Loss) | -2.94 | -2.94 | 0.65 | -17.56 | -0.29 | -26.22 |
Other Non Operating Income (Expenses) | -58.23 | 68.37 | -77.2 | -95.47 | -128.67 | -8.89 |
EBT Excluding Unusual Items | 518.47 | 568.47 | 629.83 | 455.54 | -63.19 | -1,353 |
Merger & Restructuring Charges | - | - | - | - | -5.5 | - |
Impairment of Goodwill | - | - | - | - | - | -130 |
Gain (Loss) on Sale of Investments | 1.57 | 1.57 | 2.17 | 0.35 | 1.24 | 1.4 |
Gain (Loss) on Sale of Assets | -10.64 | -10.64 | -17.74 | -13.22 | -6.43 | -0.51 |
Asset Writedown | - | - | - | - | -467.4 | -304.02 |
Other Unusual Items | -116.46 | 10.24 | 63.03 | 6.13 | 1,419 | -500.43 |
Pretax Income | 392.94 | 569.64 | 677.29 | 448.8 | 877.72 | -2,287 |
Income Tax Expense | 137.8 | 81.3 | 263.95 | 272.5 | 488.47 | -75.61 |
Earnings From Continuing Operations | 255.14 | 488.34 | 413.34 | 176.3 | 389.25 | -2,211 |
Minority Interest in Earnings | -65.64 | -44.24 | 68.21 | 117.19 | 148.08 | 276.41 |
Net Income | 189.5 | 444.1 | 481.55 | 293.49 | 537.33 | -1,935 |
Net Income to Common | 189.5 | 444.1 | 481.55 | 293.49 | 537.33 | -1,935 |
Net Income Growth | -67.51% | -7.78% | 64.08% | -45.38% | - | - |
Shares Outstanding (Basic) | 141 | 139 | 139 | 139 | 130 | 114 |
Shares Outstanding (Diluted) | 141 | 141 | 140 | 140 | 135 | 114 |
Shares Change (YoY) | -0.40% | 0.77% | 0.50% | 3.35% | 18.95% | 28.34% |
EPS (Basic) | 1.34 | 3.19 | 3.46 | 2.11 | 4.14 | -17.02 |
EPS (Diluted) | 1.34 | 3.14 | 3.43 | 2.10 | 3.97 | -17.02 |
EPS Growth | -67.35% | -8.46% | 63.33% | -47.10% | - | - |
Free Cash Flow | - | 1,082 | 988.99 | 1,184 | 1,489 | 850.97 |
Free Cash Flow Per Share | - | 7.65 | 7.04 | 8.47 | 11.01 | 7.49 |
Gross Margin | 51.47% | 53.58% | 54.78% | 54.28% | 53.80% | 52.04% |
Operating Margin | 8.43% | 8.01% | 8.13% | 8.00% | 5.69% | -3.29% |
Profit Margin | 0.77% | 2.00% | 2.52% | 1.73% | 3.84% | -19.09% |
Free Cash Flow Margin | - | 4.87% | 5.17% | 6.98% | 10.65% | 8.40% |
EBITDA | 3,615 | 3,129 | 2,671 | 2,372 | 1,784 | 656.22 |
EBITDA Margin | 14.59% | 14.08% | 13.97% | 14.00% | 12.76% | 6.48% |
D&A For EBITDA | 1,525 | 1,350 | 1,116 | 1,017 | 988.67 | 989.96 |
EBIT | 2,090 | 1,780 | 1,555 | 1,355 | 795.46 | -333.74 |
EBIT Margin | 8.43% | 8.01% | 8.13% | 8.00% | 5.69% | -3.29% |
Effective Tax Rate | 35.07% | 14.27% | 38.97% | 60.72% | 55.65% | - |
Revenue as Reported | 25,004 | 22,577 | 19,291 | 17,076 | 14,105 | 10,304 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.